ExodusPoint Capital Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

ExodusPoint Capital Management’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10,273	Closed	-$246K	–	3060
2021 Q1	$246K	Buy	+10,273	New	+$191K	﹤0.01%	1778
2019 Q4	–	Sell	-16,156	Closed	-$98K	–	2027
2019 Q3	$98K	Buy	+16,156	New	+$101K	﹤0.01%	1232

ExodusPoint Capital Management's GNMK Position: Q2 2021 in Review

ExodusPoint Capital Management sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 10,273 shares — an estimated $246K sold.

ExodusPoint Capital Management first reported a position in GNMK in Q3 2019 and held it in 2 quarters. The position peaked at $246K in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

ExodusPoint Capital Management reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
ExodusPoint Capital Management sold 10,273 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $246K.
ExodusPoint Capital Management first reported a position in GenMark Diagnostics, Inc in Q3 2019 and held it in 2 quarters.
ExodusPoint Capital Management's GenMark Diagnostics, Inc position peaked at $246K in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.